NCT00005660
- Conditions
- Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +30 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Clinical trial condition
Carcinoma, Basal Cell
Explore clinical trials studying Carcinoma, Basal Cell. Study availability and eligibility vary by location and protocol.
267 public trials
35 recruiting studies
Carcinoma, Basal Cell trial results
NCT00571363
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Neoplasms, +3 more
- Locations
-
- Ninewells Hospital and Medical School Dundee, United Kingdom
Completed
Ultrasound Biomicroscopy - Apoptosis
NCT00188370
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Hemic and Lymphatic Diseases, +20 more
- Locations
-
- Princess Margaret Hospital Toronto, Ontario, Canada
Active, Not Recruiting
A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
NCT07177638
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, +16 more
- Locations
-
- Jewish Community House of Bensonhurst Brooklyn, New York, United States
Active, Not Recruiting
Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination
NCT05935995
- Conditions
- Basal Cell Carcinoma of Skin, Carcinoma, Carcinoma, Basal Cell, +11 more
- Locations
-
- Institut de Cancerologie de Lorraine Vandœuvre-lès-Nancy, France
Active, Not Recruiting
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
NCT05078047
- Conditions
- Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
- Locations
-
- Institut de cancérologie de l'Ouest Angers, France
- Clinique Sainte Catherine Avignon, France
- Centre Hospitalier de la Côte Basque Bayonne, France
- CHU Bordeaux - Hôpial Saint André Bordeaux, France
Active, Not Recruiting
Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma
NCT07144384
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Neoplasms, +6 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients
NCT06539468
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Neoplasms, +4 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
Active, Not Recruiting
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
NCT04616248
- Conditions
- Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Basal Cell Carcinoma, +44 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States